Screener
Relay Therapeutics, Inc. RLAY Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $121.19M+6.4% | $204.59M+119% | $84.02M-32.4% | $91.56M-39.9% | $113.94M-15.0% | ||
| $928.08M+36.4% | $658.46M-11.0% | $578.28M-28.5% | $624.01M-27.9% | $680.39M-3.4% | ||
| $862K-75.1% | $1.22M-76.3% | $1.73M-70.8% | $2.36M-67.3% | $3.46M-58.6% | ||
| $789.75M+45.5% | $437.48M-29.1% | $470.5M-28.4% | $504.87M-26.5% | $542.83M-2.1% | ||
| $967.46M+32.7% | $699.61M-12.5% | $621.33M-28.7% | $670M-28.0% | $728.84M-5.7% | ||
| $50.8M+56.2% | $29.75M-19.7% | $25.58M-49.6% | $32.61M-30.6% | $32.53M-27.8% | ||
| $77.45M+22.6% | $57.43M-26.6% | $54.27M-42.0% | $62.29M-31.7% | $63.18M-30.4% | ||
| $211K+25.6% | $182K+8.3% | $168K0.0% | $168K+0.6% | $168K+26.3% | ||
| -$2.17B-15.2% | -$2.09B-15.0% | -$2.01B-15.9% | -$1.96B-17.9% | -$1.89B-19.8% | ||
| $890.01M+33.7% | $642.18M-10.9% | $567.06M-27.1% | $607.71M-27.6% | $665.66M-2.4% | ||
| $967.46M+32.7% | $699.61M-12.5% | $621.33M-28.7% | $670M-28.0% | $728.84M-5.7% |
FAQ
- What are Relay Therapeutics, Inc.'s total assets?
- Relay Therapeutics, Inc. (RLAY) holds $967.5M in total assets, up 32.7% year over year.
- How much debt does Relay Therapeutics, Inc. have?
- Relay Therapeutics, Inc. carries $30.7M in total debt against $890.0M of shareholders' equity, a debt-to-equity ratio of 0.03.
- How much cash does Relay Therapeutics, Inc. have?
- Relay Therapeutics, Inc. holds $121.2M in cash and equivalents.
- Can Relay Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 18.27 — current assets exceed current liabilities.
- Where does Relay Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Relay Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
